PICSI vs ICSI in Chennai: What Is the Added Sperm-Selection Step?

ICSI places a selected sperm into an egg using specialist laboratory equipment. PICSI adds a sperm-selection step based on binding to hyaluronan; the extra step should not be described as a separate treatment that guarantees healthier embryos. For patients in Nungambakkam, Chennai, the practical goal is to resolve the question using the existing medical record before committing to additional tests or procedures. A locality reference is for search relevance and patient planning; it is not a claim that HomeIVF operates a clinic there.

The decision starts with why ICSI is being considered at all. It may be recommended for defined male-factor concerns or a history of poor fertilisation, while conventional IVF may remain appropriate in other circumstances. PICSI is one technique for choosing which sperm to inject; it does not alter the mechanics of egg retrieval, embryo culture or transfer. Confirm that the proposed pathway addresses the particular semen and fertilisation history, not merely that a named service is available.

PICSI uses sperm binding to a hyaluronan-containing surface as a selection characteristic. That laboratory observation is not a direct test of every sperm’s DNA integrity, nor proof that a resulting embryo is genetically normal. If the clinic attributes a measurable live-birth benefit to this step, ask for the source and whether it applies to your subgroup. An embryologist should describe the criteria for choosing sperm if PICSI is declined, and what happens if there are very few usable sperm.

Request two separate explanations: the reason for ICSI and the reason for adding PICSI. If a severe sperm problem, previous fertilisation failure, or unusual sample is involved, the clinical answer may depend on different evidence. A semen analysis with collection details, repeat results where relevant, clinical male assessment and prior embryology outcomes should be reviewed together. Testing everything again without checking old reports can waste time and add cost.

Before booking an additional appointment, write down one question the test, procedure or consultation is intended to answer. Ask whether an existing report already answers it, whether timing or measurement makes that report unreliable and what the team would do with either a positive or negative result. A review that cannot change a decision may not justify another test.

Ask the laboratory for a total quote that shows IVF, ICSI, optional sperm-selection procedures, culture, freezing and later transfer as separate items. Determine whether the extra charge applies per cycle, per dish, per sample or only when it is actually used. Obtain clear written consent, including what occurs if sample quality makes the proposed technique unworkable. Do not infer that a more expensive technique necessarily means a better clinic.

An extra laboratory method or medicine should have its own purpose and informed-consent discussion. Ask whether the option is part of the centre’s ordinary validated pathway, a separately priced selection method, or a treatment being offered despite uncertain evidence. A change in embryo appearance, a laboratory score or a physiological marker does not automatically prove more live births. The comparator matters: what would happen using the standard approach without the add-on?

A counselling discussion should also make room for the female partner’s reproductive health, egg number and age-related factors. PICSI cannot compensate for every reason an embryo fails to develop. Laboratory personnel should avoid promising that the extra step will eliminate miscarriage risk. If a genetic concern is present, that is a different conversation, often involving genetic counselling rather than choosing a sperm-binding method.

Ask for the standard-cycle quotation and a second version showing the additional technique separately. The estimate should state the stage at which the fee becomes payable, what happens if the procedure cannot be used, and whether the cost applies again in a later cycle. Record the medical rationale, expected benefit, plausible risk and level of evidence, rather than accepting an unqualified claim that modern technology guarantees better outcomes.

The practical HomeIVF distinction is coordinating fertility care around the patient rather than pretending specialist procedures happen at home. Where available and appropriate, consultations, prior-report review, some blood sampling, injection assistance and subsequent follow-up may be arranged at or near home. Confirm the provider, authorisation, specimen-handling requirements and contingency plan. A clinic visit remains necessary whenever the treating clinician needs imaging, examination, consent or a procedure.

Keep facility requirements explicit: scans where indicated, egg retrieval, laboratory fertilisation, embryo culture and embryo transfer cannot be offered as home procedures. Where a referral facility is needed, verify its registration, capability, consent pathway and responsibility for results. Avoid promises about distances, travel times, doctors or partner clinics without evidence.

Nungambakkam patients can review the semen report and previous IVF records in advance and use a visit for consent and procedure planning. The sperm preparation, ICSI and any PICSI step necessarily occur inside an appropriate embryology lab. Any claim that a specific local facility offers PICSI, or that a named specialist recommends it, needs independent verification before publication. Seek urgent care for relevant warning signs: Fever, significant scrotal pain or swelling needs clinician assessment rather than waiting for a planned fertility test.

A reasonable action plan has three parts: first, check the complete existing record; second, decide whether any focused test or specialist review would alter care; third, book only the needed facility procedures and follow-up. Ask for an itemised written estimate and informed-consent notes. If the team cannot explain what a proposed add-on will change, that uncertainty belongs in the decision rather than hidden in marketing language. A sperm-selection result should not be presented as a genetic-health certificate. Where hereditary risks have been identified, genetic counselling and the correct testing pathway are separate issues. Patients can ask the clinic to write the proposed decision tree before paying for a sperm-selection technique.